Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
Research output: Contribution to journal › Article
214Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy'. Together they form a unique fingerprint.